This episode regards a United States Court of Appeals for the Federal Circuit opinion, dated October 30, 2025, concerning a patent dispute between Merck Serono S.A. and Hopewell Pharma Ventures, Inc. The case involves Merck's appeal of two consolidated inter partes reviews (IPRs) before the Patent Trial and Appeal Board (Board), which had found certain claims of two Merck patents related to an oral cladribine regimen for treating multiple sclerosis (MS) unpatentable as obvious. The primary le...
All content for Condensed IP is the property of Randy Noranbrock and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This episode regards a United States Court of Appeals for the Federal Circuit opinion, dated October 30, 2025, concerning a patent dispute between Merck Serono S.A. and Hopewell Pharma Ventures, Inc. The case involves Merck's appeal of two consolidated inter partes reviews (IPRs) before the Patent Trial and Appeal Board (Board), which had found certain claims of two Merck patents related to an oral cladribine regimen for treating multiple sclerosis (MS) unpatentable as obvious. The primary le...
Rex Medical v. Intuitive Surgical (Fed. Cir., October 2, 2025) 2024-1072
Condensed IP
10 minutes
1 month ago
Rex Medical v. Intuitive Surgical (Fed. Cir., October 2, 2025) 2024-1072
This episode concerns a decision from the United States Court of Appeals for the Federal Circuit regarding a patent infringement case, Rex Medical, L.P. v. Intuitive Surgical, Inc. The core issues addressed are damages, infringement, and patent validity of U.S. Patent No. 9,439,650, which relates to surgical stapling systems. The Federal Circuit ultimately affirmed the district court’s rulings, specifically upholding the exclusion of Rex Medical's damages expert testimony due to a failure to ...
Condensed IP
This episode regards a United States Court of Appeals for the Federal Circuit opinion, dated October 30, 2025, concerning a patent dispute between Merck Serono S.A. and Hopewell Pharma Ventures, Inc. The case involves Merck's appeal of two consolidated inter partes reviews (IPRs) before the Patent Trial and Appeal Board (Board), which had found certain claims of two Merck patents related to an oral cladribine regimen for treating multiple sclerosis (MS) unpatentable as obvious. The primary le...
